Get the Stockscreener App
1.675
4.01%
-0.07
Bioharvest Sciences Inc stock is traded at $1.675, with a volume of 10,001.
It is down -4.01% in the last 24 hours and down -5.63% over the past month.
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. The Company has two operating segments or business units: the Products business unit and the CDMO Services business unit. In identifying these operating segments, management generally follows the Company's service lines representing its main products and services. The Products Business Unit - Nutraceuticals: Research, development, manufacturing, marketing and sales of science-based health and wellness nutraceutical solutions which are manufactured and sold as dietary supplements, functional food and beverages. The CDMO Services Business Unit - comprising a Contract Development and Manufacturing Operation that offers pharmaceuticals, cosmeceuticals, nutraceuticals, and nutritions.
See More
Previous Close:
$1.745
Open:
$1.77
24h Volume:
10,001
Relative Volume:
0.55
Market Cap:
$37.97M
Revenue:
$35.16M
Net Income/Loss:
$-11.44M
P/E Ratio:
-2.8099
EPS:
-0.5961
Net Cash Flow:
$-15.44M
1W Performance:
+12.04%
1M Performance:
-5.63%
6M Performance:
-61.05%
1Y Performance:
-86.75%
1-Day Range:
$1.5301
$1.79
1-Week Range:
$1.45
$1.84
52-Week Range:
$1.371
$12.74
Bioharvest Sciences Inc Stock (BHST) Company Profile
Name
Bioharvest Sciences Inc
Sector
Industry
Phone
-
Address
-
Compare BHST vs JBS, KHC, GIS, SJM, MKC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BHST
Bioharvest Sciences Inc
|
1.675 | 37.97M | 35.16M | -11.44M | -15.44M | -0.5961 |
JBS
Jbs Nv
|
12.96 | 42.62B | 88.25B | 1.91B | -681.64M | 1.6761 |
KHC
Kraft Heinz Co
|
23.25 | 27.56B | 24.99B | -5.76B | 3.95B | -4.863 |
GIS
General Mills Inc
|
33.16 | 17.73B | 18.42B | -85.30M | 1.63B | -0.1894 |
SJM
J M Smucker Co
|
125.28 | 13.38B | 9.05B | -138.70M | 1.16B | -1.307 |
MKC
Mccormick Co Inc
|
46.33 | 12.47B | 7.39B | 1.63B | 1.02B | 6.0085 |
Bioharvest Sciences Inc Stock (BHST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-19-26 | Initiated | Roth Capital | Buy |
| May-05-25 | Initiated | Craig Hallum | Buy |
| Dec-18-24 | Initiated | Maxim Group | Buy |
Bioharvest Sciences Inc Stock (BHST) Latest News
BioHarvest Sciences Inc. (8MV0) Authorizes Buyback Up To 5% Of Shares - tradingview.com
BioHarvest Sciences Announces Share Repurchase Program - FinancialContent
BioHarvest Sciences launches buyback of up to 5% of shares | NASDAQ:BHST - Proactive financial news
BioHarvest Sciences Secures Dual Listing on Tel Aviv Stock Exchange - TipRanks
Tel Aviv exchange starts trading BioHarvest (NASDAQ: BHST) shares in new dual listing - Stock Titan
BioHarvest Sciences, Inc. Revenue Breakdown – TASE:BHST - TradingView
Diluted earnings per share (diluted EPS) of BioHarvest Sciences, Inc. – TASE:BHST - TradingView
BioHarvest Sciences Inc. (NASDAQ: BHST) to Initiate Dual Listing on Tel Aviv Stock Exchange for 22.7M Shares - Kalkine Media
Tel Aviv listing on deck for BioHarvest (NASDAQ: BHST). Trading is expected to start in 2026. - Stock Titan
Small cap wrap: Tiziana Life Sciences, Thistle Resources, Alvopetro, BioHarvest... - Proactive financial news
BioHarvest Sciences to dual-list shares on Tel Aviv exchange By Investing.com - Investing.com Nigeria
BioHarvest Sciences to dual-list shares on Tel Aviv exchange By Investing.com - Investing.com Australia
BioHarvest Sciences plans Tel Aviv Stock Exchange dual listing - Yahoo Finance
BioHarvest Sciences to dual-list shares on Tel Aviv exchange By Investing.com - Investing.com Canada
BioHarvest Sciences to dual-list shares on Tel Aviv exchange - Investing.com
BioHarvest Sciences to dual-list shares on Tel Aviv exchange By Investing.com - Investing.com South Africa
BioHarvest Sciences Registers for Dual Listing on the Tel Aviv Stock Exchange (TASE) - marketscreener.com
BioHarvest Sciences Registers for Dual Listing on the Tel Aviv Stock Exchange (TASE) - TMX Newsfile
BioHarvest Sciences plans Tel Aviv Stock Exchange dual listing - Proactive financial news
BioHarvest to dual-list shares on Nasdaq and Te... - Pluang
BioHarvest Sciences Registers for Dual Listing on the Tel Aviv Stock Exchange (TASE) - Yahoo Finance
BioHarvest Sciences Inc.'s Growth Strategy Progress Update #3 Live Video Conference November 19, 2020 @ 2:00pm E.S.T - TMX Newsfile
BioHarvest Sciences Announces New Strategic Hires for CDMO Services Business Unit - TMX Newsfile
BioHarvest Sciences: Patented plant cell culture platform drives scalable growth and strong revenue outlook - TradingView
BioHarvest (BHST): Records a 0.74% Increase to $2.06 in the Latest Session; Chart View: the $1.96 to $2.16 Range Remains in Focus at the CloseCash Flow Strong Stocks - vinanet.vn
BioHarvest (BHST) Daily Price Brief: Finishes 2.76% Down at $2.11 at the Close; Session Range View: Price Remains Between $2.00 Support and $2.22 Resistance in Latest TradingLow Volatility Picks - vinanet.vn
BioHarvest (BHST) Earnings Recap: The Available Earnings Metric Delivers a Miss in the Reported Period; The Stock Loses 1.15% in the Available RecordEarnings Manipulation Risk - vinanet.vn
symbol__ Stock Quote Price and Forecast - CNN
BHST Looks 70.0% Undervalued on GF Value™ Despite Profitability Challenges - GuruFocus
BHST Q1 2025 Earnings: Wider-Than-Expected Loss Sends Shares DownEarnings Trend Analysis - vinanet.vn
BioHarvest Sciences Inc. (NASDAQ:BHST) Just Reported And Analysts Have Been Cutting Their Estimates - simplywall.st
BHST Maintains Rating by Maxim Group -- Price Target Lowered to $5.00 - GuruFocus
BioHarvest Sciences Inc. Common Stock (NASDAQ: BHST) Stock Price, News & Analysis - Kalkine
BioHarvest Sciences Inc. (BHST) Jumps 6%: Breaking Toward Resistance at $2.31Gap Down Bounce Plays - Vinanet
BHST Maintained by Roth Capital -- Price Target Lowered to $8.00 - GuruFocus
BioHarvest at canaccord growth conference: scaling plant-cell platform By Investing.com - Investing.com Canada
BioHarvest Sciences: Patented cell culture platform secures $20–30M fragrance deal, targets $40M revenue and profitability - TradingView
BioHarvest at canaccord growth conference: scaling plant-cell platform - Investing.com
BioHarvest Sciences Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Maxim Group Maintains BioHarvest Sciences(BHST.US) With Buy Rating, Maintains Target Price $5 - Moomoo
BioHarvest Sciences Inc. Common Stock (NASDAQ: BHST) Stock Price, News & Analysis - kalkine.ca
BioHarvest Sciences (BHST) Q2 2026 Earnings Call Transcript - AOL.com
BioHarvest Sciences (BHST) Q2 2026 Earnings Call Transcript - The Globe and Mail
BioHarvest Sciences Inc (BHST) (Q2 2026) Earnings Call Highlights: Strategic Pivot to ... By GuruFocus - Investing.com Canada
BioHarvest Sciences Inc (BHST) (Q2 2026) Earnings Call Highlight - GuruFocus
BioHarvest Sciences Inc (BHST) (Q2 2026) Earnings Call Highlights: Strategic Pivot to ... - Yahoo Finance
What Could BioHarvest Sciences (NASDAQ:BHST) Quarterly Update Show? - Kalkine Media
What Will BioHarvest Sciences (NASDAQ:BHST) Add to Nasdaq Focus? - Kalkine Media
BioHarvest Sciences Inc. Common Stock Q2 2026 Earnings Call Summary - Yahoo Finance
Earnings call transcript: BioHarvest Sciences posts smaller Q2 2026 loss By Investing.com - Investing.com Canada
Bioharvest Sciences Inc Stock (BHST) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.65%
5.84%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):